Biomarin Pharmaceutical Stock Price History

BMRN Stock  USD 92.06  2.57  2.87%   
If you're considering investing in Biomarin Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biomarin Pharmaceutical stands at 92.06, as last reported on the 24th of April, with the highest price reaching 92.22 and the lowest price hitting 89.93 during the day. We consider Biomarin Pharmaceutical very steady. Biomarin Pharmaceutical secures Sharpe Ratio (or Efficiency) of 0.0174, which signifies that the company had a 0.0174% return per unit of risk over the last 3 months. We have found thirty technical indicators for Biomarin Pharmaceutical, which you can use to evaluate the volatility of the firm. Please confirm Biomarin Pharmaceutical's Mean Deviation of 0.9635, risk adjusted performance of 0.0158, and Downside Deviation of 1.19 to double-check if the risk estimate we provide is consistent with the expected return of 0.0216%.
  
Biomarin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0174

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBMRN

Estimated Market Risk

 1.24
  actual daily
10
90% of assets are more volatile

Expected Return

 0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average Biomarin Pharmaceutical is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biomarin Pharmaceutical by adding it to a well-diversified portfolio.

Biomarin Pharmaceutical Stock Price History Chart

There are several ways to analyze Biomarin Stock price data. The simplest method is using a basic Biomarin candlestick price chart, which shows Biomarin Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceApril 12, 202492.22
Lowest PriceMarch 18, 202483.81

Biomarin Pharmaceutical April 24, 2024 Stock Price Synopsis

Various analyses of Biomarin Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Biomarin Stock. It can be used to describe the percentage change in the price of Biomarin Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Biomarin Stock.
Biomarin Pharmaceutical Price Daily Balance Of Power 1.12 
Biomarin Pharmaceutical Price Action Indicator 2.27 
Biomarin Pharmaceutical Price Rate Of Daily Change 1.03 

Biomarin Pharmaceutical April 24, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Biomarin Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Biomarin Pharmaceutical intraday prices and daily technical indicators to check the level of noise trading in Biomarin Stock and then apply it to test your longer-term investment strategies against Biomarin.

Biomarin Stock Price History Data

The price series of Biomarin Pharmaceutical for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 8.41 with a coefficient of variation of 2.57. The prices are distributed with arithmetic mean of 88.1. The median price for the last 90 days is 88.15.
OpenHighLowCloseVolume
04/24/2024
 90.03  92.22  89.93  92.06 
04/23/2024 90.03  92.22  89.93  92.06  1,299,078 
04/22/2024 89.46  89.81  88.89  89.49  1,257,348 
04/19/2024 89.67  90.18  88.29  88.63  1,778,607 
04/18/2024 90.25  91.21  89.78  90.07  944,850 
04/17/2024 91.14  91.53  90.02  90.47  1,282,481 
04/16/2024 90.93  91.78  90.16  90.87  1,235,787 
04/15/2024 92.58  93.36  90.96  91.51  1,942,193 
04/12/2024 91.26  93.26  91.09  92.22  2,419,825 
04/11/2024 90.99  91.59  89.33  91.46  2,296,903 
04/10/2024 88.38  90.41  87.79  90.21  2,204,505 
04/09/2024 87.35  89.19  87.35  88.98  1,178,105 
04/08/2024 87.00  88.11  86.95  87.28  1,344,968 
04/05/2024 86.46  87.23  86.01  86.95  828,855 
04/04/2024 86.78  88.13  86.63  86.89  1,151,883 
04/03/2024 86.48  87.72  86.48  86.78  1,166,479 
04/02/2024 86.25  86.94  85.62  86.80  1,410,588 
04/01/2024 86.98  87.31  86.09  87.10  715,532 
03/28/2024 88.34  88.66  86.65  87.34  1,027,708 
03/27/2024 88.18  88.74  87.92  88.61  1,031,697 
03/26/2024 86.94  87.86  86.50  87.74  1,346,939 
03/25/2024 84.70  86.99  84.70  86.52  1,409,254 
03/22/2024 84.35  85.29  83.90  85.13  876,720 
03/21/2024 84.99  85.25  83.84  84.11  919,107 
03/20/2024 85.01  85.19  83.82  84.76  879,941 
03/19/2024 84.43  85.60  83.77  85.27  1,300,210 
03/18/2024 84.13  84.67  83.66  83.81  1,404,481 
03/15/2024 84.56  84.75  83.44  83.87  1,185,802 
03/14/2024 84.61  84.94  83.53  84.39  1,244,299 
03/13/2024 85.19  85.71  84.57  84.77  1,312,690 
03/12/2024 86.27  86.69  84.87  85.18  1,027,892 
03/11/2024 85.69  86.82  85.53  86.00  1,368,855 
03/08/2024 85.90  86.55  85.70  85.95  1,252,138 
03/07/2024 87.21  87.87  85.63  85.89  1,224,150 
03/06/2024 87.25  87.60  86.11  86.77  1,007,066 
03/05/2024 87.09  87.42  85.01  86.02  1,710,509 
03/04/2024 87.57  87.92  86.51  87.72  800,734 
03/01/2024 86.39  88.28  85.88  87.14  1,927,864 
02/29/2024 88.80  89.00  86.02  86.28  2,604,479 
02/28/2024 89.82  90.28  88.32  88.40  1,172,821 
02/27/2024 90.64  92.16  90.06  90.68  1,249,147 
02/26/2024 90.93  91.23  88.11  90.10  1,470,158 
02/23/2024 90.94  94.15  89.48  91.24  3,652,648 
02/22/2024 89.30  90.50  88.63  89.97  1,652,683 
02/21/2024 88.67  89.20  87.40  88.54  1,268,429 
02/20/2024 88.14  90.26  87.53  88.67  1,859,731 
02/16/2024 88.30  89.49  87.85  88.77  1,054,480 
02/15/2024 86.11  88.73  85.97  88.30  1,990,541 
02/14/2024 86.24  86.81  85.71  86.01  1,233,336 
02/13/2024 87.15  87.39  85.60  86.13  925,484 
02/12/2024 88.47  89.16  88.10  88.18  1,279,650 
02/09/2024 88.28  88.64  87.83  88.46  1,355,301 
02/08/2024 89.77  90.18  87.43  88.15  1,140,939 
02/07/2024 89.46  91.06  88.41  89.66  2,851,101 
02/06/2024 88.12  90.05  87.49  89.80  1,608,956 
02/05/2024 87.76  88.33  87.08  87.72  1,133,273 
02/02/2024 87.91  88.43  87.29  88.11  1,396,296 
02/01/2024 87.72  88.87  87.26  88.74  1,429,543 
01/31/2024 89.67  90.01  87.63  88.08  1,121,492 
01/30/2024 91.59  91.59  89.43  89.62  1,675,898 
01/29/2024 91.00  91.78  89.46  91.78  691,154 

About Biomarin Pharmaceutical Stock history

Biomarin Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biomarin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biomarin Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biomarin Pharmaceutical stock prices may prove useful in developing a viable investing in Biomarin Pharmaceutical
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. The company was incorporated in 1996 and is headquartered in San Rafael, California. Biomarin Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3045 people.

Biomarin Pharmaceutical Stock Technical Analysis

Biomarin Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biomarin Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biomarin Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module

Biomarin Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Biomarin Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Biomarin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biomarin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Biomarin Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomarin Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomarin Pharmaceutical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomarin Pharmaceutical Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Biomarin Stock analysis

When running Biomarin Pharmaceutical's price analysis, check to measure Biomarin Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomarin Pharmaceutical is operating at the current time. Most of Biomarin Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biomarin Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomarin Pharmaceutical's price. Additionally, you may evaluate how the addition of Biomarin Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Biomarin Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomarin Pharmaceutical. If investors know Biomarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomarin Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomarin Pharmaceutical is measured differently than its book value, which is the value of Biomarin that is recorded on the company's balance sheet. Investors also form their own opinion of Biomarin Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biomarin Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomarin Pharmaceutical's market value can be influenced by many factors that don't directly affect Biomarin Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomarin Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomarin Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomarin Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.